. 2023 Oct 3;20(10):e1004288.

doi: 10.1371/journal.pmed.1004288. eCollection 2023 Oct.

Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment

Aditya Narayan¹, Argita D Salindri¹, Salmaan Keshavjee^{2

3}, Monde Muyoyeta⁴, Kavindhran Velen⁵, Zulma V Rueda^{6

7}, Julio Croda^{8

9

10}, Salome Charalambous^{5

11}, Alberto L García-Basteiro^{12

13

14}, Sheela V Shenoi⁹, Crhistinne C M Gonçalves⁸, Liliane Ferreira da Silva⁸, Lia G Possuelo¹⁵, Sarita Aguirre¹⁶, Gladys Estigarribia¹⁷, Guillermo Sequera¹⁸, Louis Grandjean¹⁹, Lily Telisinghe²⁰, Michael E Herce^{4

21}, Fernanda Dockhorn²², Frederick L Altice⁹, Jason R Andrews¹

Affiliations

¹ Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America.
² Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
³ Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
⁴ Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
⁵ Implementation Division, The Aurum Institute, Johannesburg, South Africa.
⁶ Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.
⁷ Research Department, School of Medicine, Universidad Pontificia Bolivariana, Medellin, Colombia.
⁸ School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
⁹ Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.
¹⁰ Oswaldo Cruz Foundation, Campo Grande, Brazil.
¹¹ Wits School of Public Health, Johannesburg, South Africa.
¹² ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
¹³ Manhiça Health Research Center, Maputo, Mozambique.
¹⁴ Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.
¹⁵ Department of Life Sciences, Santa Cruz do Sul University, Santa Cruz do Sul, Brazil.
¹⁶ National Tuberculosis Control Program, Ministry of Public Health and Social Welfare (MSPyBS), Asunción, Paraguay.
¹⁷ Instituto Regional de Investigación en Salud, Caaguazú, Paraguay.
¹⁸ Department of Public Health, Facultad de Ciencias Médicas, Universidad Nacional de Asunción, Asunción, Paraguay.
¹⁹ Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom.
²⁰ London School of Hygiene and Tropical Medicine, London, United Kingdom.
²¹ Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
²² Ministry of Health, Health and Environmental Surveillance Secretariat, General Coordination for Tuberculosis, Endemic Mycoses and Non-Tuberculous Mycobacteria Surveillance, Brasília, (DF) Brazil.

PMID: 37788448
PMCID: PMC10547494
DOI: 10.1371/journal.pmed.1004288

Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment

Aditya Narayan et al. PLoS Med. 2023.

. 2023 Oct 3;20(10):e1004288.

doi: 10.1371/journal.pmed.1004288. eCollection 2023 Oct.

Authors

Affiliations

¹ Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America.
² Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
³ Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
⁴ Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
⁵ Implementation Division, The Aurum Institute, Johannesburg, South Africa.
⁶ Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.
⁷ Research Department, School of Medicine, Universidad Pontificia Bolivariana, Medellin, Colombia.
⁸ School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
⁹ Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.
¹⁰ Oswaldo Cruz Foundation, Campo Grande, Brazil.
¹¹ Wits School of Public Health, Johannesburg, South Africa.
¹² ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
¹³ Manhiça Health Research Center, Maputo, Mozambique.
¹⁴ Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.
¹⁵ Department of Life Sciences, Santa Cruz do Sul University, Santa Cruz do Sul, Brazil.
¹⁶ National Tuberculosis Control Program, Ministry of Public Health and Social Welfare (MSPyBS), Asunción, Paraguay.
¹⁷ Instituto Regional de Investigación en Salud, Caaguazú, Paraguay.
¹⁸ Department of Public Health, Facultad de Ciencias Médicas, Universidad Nacional de Asunción, Asunción, Paraguay.
¹⁹ Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom.
²⁰ London School of Hygiene and Tropical Medicine, London, United Kingdom.
²¹ Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
²² Ministry of Health, Health and Environmental Surveillance Secretariat, General Coordination for Tuberculosis, Endemic Mycoses and Non-Tuberculous Mycobacteria Surveillance, Brasília, (DF) Brazil.

PMID: 37788448
PMCID: PMC10547494
DOI: 10.1371/journal.pmed.1004288

Abstract

In this Policy Forum piece, Aditya Narayan and colleagues discuss the challenges and opportunities for tuberculosis preventive treatment in carceral settings.

Copyright: © 2023 Narayan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PubMed Disclaimer

Conflict of interest statement

The spouse of SS was employed by Merck Pharmaceuticals 1997-2007 and retains stock in his retirement account. There is no conflict of interest with the submitted work, but is included in the interest of full disclosure. The other authors have declared that no competing interests exist.

Cited by

Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study.
van Lieshout Titan A, Klaassen F, Pelissari DM, de Barros Silva JN Júnior, Alves K, Alves LC, Sanchez M, Bartholomay P, Johansen FDC, Croda J, Andrews JR, Castro MC, Cohen T, Vuik C, Menzies NA. van Lieshout Titan A, et al. Lancet Glob Health. 2024 Sep;12(9):e1446-e1455. doi: 10.1016/S2214-109X(24)00221-3. Lancet Glob Health. 2024. PMID: 39151980 Free PMC article.
Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected impacts of policy alternatives: A mathematical modeling study.
Liu YE, Mabene Y, Camelo S, Rueda ZV, Pelissari DM, Johansen FDC, Huaman MA, Avalos-Cruz T, Alarcón VA, Ladutke LM, Bergman M, Cohen T, Goldhaber-Fiebert JD, Croda J, Andrews JR. Liu YE, et al. medRxiv [Preprint]. 2024 Jul 22:2024.04.23.24306238. doi: 10.1101/2024.04.23.24306238. medRxiv. 2024. Update in: Lancet Public Health. 2024 Nov;9(11):e841-e851. doi: 10.1016/S2468-2667(24)00192-0. PMID: 39108530 Free PMC article. Updated. Preprint.
Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected effects of policy alternatives: a mathematical modelling study.
Liu YE, Mabene Y, Camelo S, Rueda ZV, Pelissari DM, Dockhorn Costa Johansen F, Huaman MA, Avalos-Cruz T, Alarcón VA, Ladutke LM, Bergman M, Cohen T, Goldhaber-Fiebert JD, Croda J, Andrews JR. Liu YE, et al. Lancet Public Health. 2024 Nov;9(11):e841-e851. doi: 10.1016/S2468-2667(24)00192-0. Epub 2024 Oct 15. Lancet Public Health. 2024. PMID: 39419058 Free PMC article.

References

1. World Health Organization. Global Tuberculosis Report: 2022. Geneva, Switzerland; 2022.
1. Cords O, Martinez L, Warren JL, O’Marr JM, Walter KS, Cohen T, et al.. Incidence and prevalence of tuberculosis in incarcerated populations: a systematic review and meta-analysis. Lancet Public Health. 2021;6:e300–e308. doi: 10.1016/S2468-2667(21)00025-6 - DOI - PMC - PubMed
1. World Prison Brief data | World Prison Brief. [Accessed 2023 Jul 10]. Available from: https://www.prisonstudies.org/world-prison-brief-data
1. Warren JL, Grandjean L, Moore DAJ, Lithgow A, Coronel J, Sheen P, et al.. Investigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis. BMC Med. 2018;16:122. doi: 10.1186/s12916-018-1111-x - DOI - PMC - PubMed
1. Walter KS, Martinez L, Arakaki-Sanchez D, Sequera VG, Estigarribia Sanabria G, Cohen T, et al.. The escalating tuberculosis crisis in central and South American prisons. Lancet. 2021;397:1591–1596. doi: 10.1016/S0140-6736(20)32578-2 - DOI - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment

Affiliations

Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Abstract

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical